Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikas Prasad

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Cancers|June 26, 2025
Advances in Molecular Imaging for Neuroendocrine NeoplasmsBradley Girod, Vikas Prasad
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2018
Tumor Lysis Syndrome: A Rare but Serious Complication of Radioligand TherapiesKai Huang, Winfried Brenner, Vikas Prasad
Frontiers of Radiation Therapy and Oncology|December 4, 2009
FDG-PET/CT in lung cancer: an updateRichard P Baum, Cyprian Świętaszczyk, Vikas Prasad
Translational Oncology|November 30, 2021
Nephrotoxicity after radionuclide therapiesAshwin Singh Parihar, Sejal Chopra, Vikas Prasad
Frontiers in Endocrinology|April 24, 2018
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell LinesSamantha Exner, Vikas Prasad, Bertram Wiedenmann, et al.
Frontiers in Oncology|February 25, 2021
mTOR Inhibitors as Radiosensitizers in Neuroendocrine NeoplasmsSamantha Exner, Gerard Arrey, Vikas Prasad, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesionsHarun Badakhshi, Reinhold Graf, Vikas Prasad, et al.
International Journal of Surgical Pathology|June 16, 2026
Uncommon Tumor, Unusual Site, and Unconventional Behavior: Report of a Gastric Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor (CoGNET) With MetastasesAlicia Dessain, Vikas Prasad, Nikolaos Trikalinos, et al.
Nuclear Medicine Communications|November 6, 2025
Chemokine receptor-4-targeted imaging with [68Ga]Ga-Pentixafor PET: unveiling its diagnostic and prognostic potential across cancers: a systematic reviewMina Taghizadehasl, Vikas Prasad, Hesamoddin Roustaei, et al.
Journal of Neuroendocrinology|February 17, 2025
Frontiers in radiopharmaceuticals for neuroendocrine tumorsAmeya D Puranik, Indraja D Dev, Vikas Prasad
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Cancers|June 26, 2025
Advances in Molecular Imaging for Neuroendocrine NeoplasmsBradley Girod, Vikas Prasad
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2018
Tumor Lysis Syndrome: A Rare but Serious Complication of Radioligand TherapiesKai Huang, Winfried Brenner, Vikas Prasad
Frontiers of Radiation Therapy and Oncology|December 4, 2009
FDG-PET/CT in lung cancer: an updateRichard P Baum, Cyprian Świętaszczyk, Vikas Prasad
Translational Oncology|November 30, 2021
Nephrotoxicity after radionuclide therapiesAshwin Singh Parihar, Sejal Chopra, Vikas Prasad
Frontiers in Endocrinology|April 24, 2018
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell LinesSamantha Exner, Vikas Prasad, Bertram Wiedenmann, et al.
Frontiers in Oncology|February 25, 2021
mTOR Inhibitors as Radiosensitizers in Neuroendocrine NeoplasmsSamantha Exner, Gerard Arrey, Vikas Prasad, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesionsHarun Badakhshi, Reinhold Graf, Vikas Prasad, et al.
International Journal of Surgical Pathology|June 16, 2026
Uncommon Tumor, Unusual Site, and Unconventional Behavior: Report of a Gastric Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor (CoGNET) With MetastasesAlicia Dessain, Vikas Prasad, Nikolaos Trikalinos, et al.
Nuclear Medicine Communications|November 6, 2025
Chemokine receptor-4-targeted imaging with [68Ga]Ga-Pentixafor PET: unveiling its diagnostic and prognostic potential across cancers: a systematic reviewMina Taghizadehasl, Vikas Prasad, Hesamoddin Roustaei, et al.
Journal of Neuroendocrinology|February 17, 2025
Frontiers in radiopharmaceuticals for neuroendocrine tumorsAmeya D Puranik, Indraja D Dev, Vikas Prasad
Pageof 14